1. Ihara M, Yamamoto Y, Hattori Y, Liu W, Kobayashi H, Ishiyama H, Yoshimoto T, Miyawaki S, Clausen T, Bang OY, Steinberg GK, Tournier-Lasserve E, Koizumi A. Moyamoya disease: diagnosis and interventions. Lancet Neurol. 2022 May 20;S1474-4422(22)00165-X. doi: 10.1016/S1474-4422(22)00165-X.
2. Yamaguchi E, Yoshimoto T, Ogura S, Saito K, Saito S, Nishimura K, Toyoda K, Koga M, Ihara M. Association of the RNF213 p.R4810K Variant with the Outer Diameter of Cervical Arteries in Ischemic Stroke Patients. Stroke Vasc Interv Neurol .doi: 10.1161/SVIN.121.000298
3. 猪原匡史.血栓形成と凝固異常.下畑享良(編)COVID-19神経ハンドブック―急性期,後遺症からワクチン副反応まで― 中外医学社.出版中
4. 猪原匡史.ゲノム医療実装化のためのゲノム・オミックス研究の展望-脳卒中領域-.Progress in Medicine 2022; 42(2): 67-72.
5. Ohara M, Yoshimoto T, Okazaki S, Gon Y, Todo K, Sasaki T, Takasugi J, Ohara N, Ihara M, Mochizuki H. RNF213 p.R4810K Variant Carriers with Intracranial Arterial Stenosis Have a Low Atherosclerotic Burden. J Atheroscler Thromb 2021 Dec 25. doi: 10.5551/jat.63379.
6. Eto F, Yoshimoto T, Okazaki S, Nishimura K, Ogura S, Yamaguchi E, Fukuma K, Saito S, Washida K, Koga M, Toyoda K, Morimoto T, Maruyama H, Koizumi A, Ihara M. RNF213 p.R4810K (c.14429G>A) variant determines anatomical variations of the circle of Willis in cerebrovascular disease. Front Aging Neurosci 2021;13:681743. doi: 10.3389/fnagi.2021.681743
7. Satoshi Saito, Kaori Shinmyozu, Daisuke Kawakami, Miho Yamauchi, Shuhei Ikeda, Yorito Hattori, Rintaro Yamamoto, Naoki Hayakawa, Masafumi Ihara. Conversion from cilostazol to OPC-13015 linked to mitigation of cognitive impairment. Alzheimers Dement (N Y), 2021 May 27;7(1):e12182. doi: 10.1002/trc2.12182
8. Tanaka T, Ihara M, Fukuma K, Yamamoto H, Washida K, Kimura S, Kada A, Miyata S, Miyata T, Nagatsuka K. Influence of renal impairment and genetic subtypes on warfarin control in Japanese patients. Genes 2021;12(10):1537. doi: 10.3390/genes12101537.
9. Hoshino H, Toyoda K, Omae K, Ishida N, Uchiyama S, Kimura K, Sakai N, Okada Y, Tanaka K, Origasa H, Naritomi H, Houkin K, Yamaguchi K, Isobe M, Minematsu K, Matsumoto M, Tominaga T, Tomimoto H, Terayama Y, Yasuda S, Yamaguchi T; CSPS.com Trial Investigators. Dual antiplatelet therapy using cilostazol with aspirin or clopidogrel: subanalysis of the CSPS.com trial. Stroke. 2021 Nov;52(11):3430-3439. doi: 10.1161/STROKEAHA.121.034378.
10. Uchiyama S, Toyoda K, Omae K, Saita R, Kimura K, Hoshino H, Sakai N, Okada Y, Tanaka K, Origasa H, Naritomi H, Houkin K, Yamaguchi K, Isobe M, Minematsu K, Matsumoto M, Tominaga T, Tomimoto H, Terayama Y, Yasuda S, Yamaguchi T. Dual antiplatelet therapy using cilostazol in patients with stroke and intracranial arterial stenosis. J Am Heart Assoc. 2021 Oct 19;10(20):e022575. doi: 10.1161/JAHA.121.022575.